ducovest

IAK:NYE-iShares U.S. Insurance ETF (USD)

ETF | Financial |

Last Closing

USD 129.67

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.06M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Currency: USD

Country : USA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-21 )

Largest Industry Peers for Financial

Symbol Name Price(Change) Market Cap
XLF Financial Select Sector SPDR®..

N/A

 USD 42.83B
VFH Vanguard Financials Index Fund..

N/A

 USD 10.12B
FNCL Fidelity® MSCI Financials Ind..

N/A

 USD 1.78B
BIZD VanEck BDC Income ETF

N/A

 USD 1.18B
FXO First Trust Financials AlphaDE..

N/A

 USD 0.89B
VPC Virtus Private Credit ETF

N/A

 USD 0.05B
BDCZ UBS AG London Branch ELKS 4

N/A

 USD 0.03B
IYF iShares U.S. Financials ETF

N/A

 N/A
IYG iShares U.S. Financial Service..

N/A

 N/A
IAI iShares U.S. Broker-Dealers & ..

N/A

 N/A

ETFs Containing IAK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Financial) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 29.51% 100% F 90% A-
Dividend Return 0.63% 6% D- 14% F
Total Return 30.15% 100% F 89% A-
Trailing 12 Months  
Capital Gain 37.74% 71% C- 85% B
Dividend Return 1.66% 24% F 28% F
Total Return 39.39% 71% C- 84% B
Trailing 5 Years  
Capital Gain 79.67% 88% B+ 81% B-
Dividend Return 8.40% 29% F 28% F
Total Return 88.07% 88% B+ 81% B-
Average Annual (5 Year Horizon)  
Capital Gain 16.76% 82% B 80% B-
Dividend Return 18.45% 76% C+ 80% B-
Total Return 1.69% 41% F 39% F
Risk Return Profile  
Volatility (Standard Deviation) 18.82% 94% A 54% F
Risk Adjusted Return 98.02% 100% F 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.